These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28303442)

  • 1. Different Immunological Pathways Underlie the Immune Response to Pneumococcal Polysaccharides.
    Moens L; Picard C; Shahrooei M; Wuyts G; Liston A; Fischer A; Bossuyt X
    J Clin Immunol; 2017 Apr; 37(3):277-278. PubMed ID: 28303442
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Using Different Response Criteria for Pneumococcal Polysaccharide Vaccination for Assessment of Humoral Immune Status.
    Hoffman TW; van Kessel DA; Rijkers GT
    J Clin Immunol; 2018 Feb; 38(2):149-152. PubMed ID: 29247371
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
    Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal and systemic immunization with pneumococcal polysaccharide type 3, 4 and 14 in the rat.
    van den Dobbelsteen GP; Brunekreef K; Sminia T; van Rees EP
    Adv Exp Med Biol; 1995; 371B():1605-10. PubMed ID: 7502866
    [No Abstract]   [Full Text] [Related]  

  • 5. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
    da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal vaccines in adults: assessing the evolving evidence.
    Grabenstein JD; Manoff SB
    Vaccine; 2011 Aug; 29(37):6149-54. PubMed ID: 21763386
    [No Abstract]   [Full Text] [Related]  

  • 7. Fold-increase in antibody titer upon vaccination with pneumococcal unconjugated polysaccharide vaccine.
    Borgers H; Meyts I; De Boeck K; Raes M; Sauer K; Proesmans M; Moens L; Jeurissen A; Flamaing J; Peetermans WE; Verhaegen J; Bossuyt X
    Clin Immunol; 2012 Nov; 145(2):136-8. PubMed ID: 23026475
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides.
    Denoël P; Godfroid F; Hermand P; Verlant V; Poolman J
    Vaccine; 2011 Sep; 29(38):6451-3. PubMed ID: 21315695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.
    Goulart C; Rodriguez D; Kanno AI; Converso TR; Lu YJ; Malley R; Leite LCC
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsular Polysaccharide (CPS) Release by Serotype 3 Pneumococcal Strains Reduces the Protective Effect of Anti-Type 3 CPS Antibodies.
    Choi EH; Zhang F; Lu YJ; Malley R
    Clin Vaccine Immunol; 2016 Feb; 23(2):162-7. PubMed ID: 26677201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of the immunologic response to pneumococcal capsular polysaccharides.
    Musher DM; Watson DA; Baughn RE
    Vaccine; 2000 Nov; 19(6):623-7. PubMed ID: 11090713
    [No Abstract]   [Full Text] [Related]  

  • 12. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.
    Malley R; Srivastava A; Lipsitch M; Thompson CM; Watkins C; Tzianabos A; Anderson PW
    Infect Immun; 2006 Apr; 74(4):2187-95. PubMed ID: 16552049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age- and serotype-dependent antibody response to pneumococcal polysaccharides.
    Bossuyt X; Borgers H; Moens L; Verbinnen B; Meyts I
    J Allergy Clin Immunol; 2011 Apr; 127(4):1079-80; author reply 1080-1. PubMed ID: 21306761
    [No Abstract]   [Full Text] [Related]  

  • 16. T cells control the generation of nanomolar-affinity anti-glycan antibodies.
    Polonskaya Z; Deng S; Sarkar A; Kain L; Comellas-Aragones M; McKay CS; Kaczanowska K; Holt M; McBride R; Palomo V; Self KM; Taylor S; Irimia A; Mehta SR; Dan JM; Brigger M; Crotty S; Schoenberger SP; Paulson JC; Wilson IA; Savage PB; Finn MG; Teyton L
    J Clin Invest; 2017 Apr; 127(4):1491-1504. PubMed ID: 28287405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of transplant patient to pneumococcal vaccine.
    Arnold WC; Steele RW; Rastogi SP; Flanigan WJ
    Proc Clin Dial Transplant Forum; 1980; 10():57-61. PubMed ID: 7050994
    [No Abstract]   [Full Text] [Related]  

  • 19. IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal mice.
    Olafsdottir TA; Lingnau K; Nagy E; Jonsdottir I
    Scand J Immunol; 2009 Mar; 69(3):194-202. PubMed ID: 19281531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides.
    Breukels MA; Zandvoort A; van Den Dobbelsteen GP; van Den Muijsenberg A; Lodewijk ME; Beurret M; Klok PA; Timens W; Rijkers GT
    Infect Immun; 2001 Dec; 69(12):7583-7. PubMed ID: 11705936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.